These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 12108914)

  • 1. Clinical research: the best or worst of times?
    Ferrara JL; Wingard JR
    Biol Blood Marrow Transplant; 2002; 8(6):293-4. PubMed ID: 12108914
    [No Abstract]   [Full Text] [Related]  

  • 2. Reporting of adverse event data in hematopoietic stem cell transplantation clinical trials involving investigational new drugs or devices: a report from the William Guy Forbeck Foundation 2001 focus meeting on clinical trials in hematopoietic stem cell transplantation.
    Martin PJ; Antin JH; Weisdorf DJ; Paton V; Horowitz MM
    Biol Blood Marrow Transplant; 2002; 8(6):295-302. PubMed ID: 12108915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The GCP directive--consequences for clinical drug research].
    Gluud CN
    Ugeskr Laeger; 2003 Apr; 165(16):1662-4. PubMed ID: 12756824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of the Danish Medical Products Agency in clinical trials].
    Simonsen AC
    Ugeskr Laeger; 2003 Apr; 165(16):1653-6. PubMed ID: 12756821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The inspection by the Danish Medical Products Agency of drug clinical trials].
    Jacobsen E; Stilbo I
    Ugeskr Laeger; 2003 Apr; 165(16):1656-8. PubMed ID: 12756822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The 12th German Drug Law (AMG) amendment: an obstruction for non-commercial clinical trials?].
    Schwarz S; Frölich L; Striebel JP; Hennerici MG
    Dtsch Med Wochenschr; 2007 Jan; 132(3):108-12. PubMed ID: 17219346
    [No Abstract]   [Full Text] [Related]  

  • 7. [Network for investigation of medicinal products in children].
    Kassaï B; Treluyer JM; Jacqz-Aigrain E; Pons G
    Arch Pediatr; 2006 Jun; 13(6):631-4. PubMed ID: 16697606
    [No Abstract]   [Full Text] [Related]  

  • 8. [European network for investigation of medicinal products in children (Medichildren)].
    Pons G
    Arch Pediatr; 2006 Jun; 13(6):631. PubMed ID: 16713209
    [No Abstract]   [Full Text] [Related]  

  • 9. Obstacles encountered in designing antiepileptic drug trials.
    French JA
    Epilepsy Res Suppl; 1993; 10():81-9. PubMed ID: 8251107
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of the pharmacist in investigational AED trials.
    Graves NM
    Epilepsy Res Suppl; 1993; 10():201-9. PubMed ID: 8251098
    [No Abstract]   [Full Text] [Related]  

  • 11. Establishing pan-European clinical trials: regulatory compliance and other practical considerations.
    Grienenberger A
    J Biolaw Bus; 2004; 7(4):58-63. PubMed ID: 15675097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Recommendations concerning regulatory and legal aspects" contribution to the European task force on disease modifying trials in Alzheimer's disease.
    Rapp L
    J Nutr Health Aging; 2006; 10(2):139-41. PubMed ID: 16554950
    [No Abstract]   [Full Text] [Related]  

  • 13. Short patent lives jeopardize drug and patient safety.
    Hondeghem LM; De Clerck F; Camm J
    J Cardiovasc Pharmacol; 2007 Oct; 50(4):353-7. PubMed ID: 18049301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fundamental principles of clinical trials].
    Skarke C; Geisslinger G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Apr; 48(4):401-7. PubMed ID: 15830250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Informing prospective research subjects of the influence of regulatory requirements for drug approval on the design of clinical trials in oncology.
    Markman M
    Cancer; 2007 Mar; 109(6):1003-6. PubMed ID: 17311306
    [No Abstract]   [Full Text] [Related]  

  • 16. [ICH-GCP Guideline: quality assurance of clinical trials. Status and perspectives].
    Englev E; Petersen KP
    Ugeskr Laeger; 2003 Apr; 165(16):1659-62. PubMed ID: 12756823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Who will regulate the regulators?
    Goldman JM
    Bone Marrow Transplant; 2004 Dec; 34(12):1013-4. PubMed ID: 15573085
    [No Abstract]   [Full Text] [Related]  

  • 18. New regulatory rules for clinical trials in the United States and the European Union: key points and comparisons.
    Miossec M; Miossec P
    Arthritis Rheum; 2006 Dec; 54(12):3735-40. PubMed ID: 17133535
    [No Abstract]   [Full Text] [Related]  

  • 19. The right to a trial: Should dying patients have access to experimental drugs?
    Groopman J
    New Yorker; 2006 Dec; ():40-7. PubMed ID: 17176539
    [No Abstract]   [Full Text] [Related]  

  • 20. How pharmacogenomics will impact the federal regulation of clinical trials and the new drug approval process.
    Binzak BA
    Food Drug Law J; 2003; 58(1):103-27. PubMed ID: 12739592
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.